Cited by 475Hepatitis C virus researchHealth Promotion and Cardiovascular PreventionLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.

Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.

Moyer, Virginia A.·2013·Annals of Internal Medicine

DOI 10.7326/0003-4819-159-5-201309030-00672

Open this paper in CoChat — free account

Abstract

DESCRIPTION: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for and treatment of hepatitis C virus (HCV) infection in asymptomatic adults. METHODS: The Agency for Healthcare Research and Quality commissioned 2 systematic reviews on screening for and treatment of HCV infection in asymptomatic adults, focusing on evidence gaps identified in the previous USPSTF recommendation and new studies published since 2004. The evidence on screening for HCV in pregnant women was also considered. POPULATION: This recommendation applies to all asymptomatic adults without known liver disease or functional abnormalities. RECOMMENDATION: The USPSTF recommends screening for HCV infection in persons at high risk for infection. The USPSTF also recommends offering 1-time screening for HCV infection to adults born between 1945 and 1965. (B recommendation).

Integrity signals

Registry

Crossref · 10.7326/0003-4819-159-5-201309030-00672

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2008) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,986
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H. H., Dufour, J., Lammert, F., Duarte‐Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,507
Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease
(U.S.), C. F. D. C. A. P. (1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,217
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y. T., Holtzman, D. J., Teo, C., Jewett, A., Baack, B. N., Rein, D. B., Patel, N., et al. (2012) · PubMed · Cited by 991
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
Morgan, R. L., Baack, B. N., Smith, B. D., Yartel, A. K., Pitasi, M. A., & Falck-Ytter, Y. T. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 849
A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
Backus, L. I., Boothroyd, D. B., Phillips, B. R., Belperio, P. S., Halloran, J. P., & Mole, L. A. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.004 · Cited by 484
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Chou, R., & Wasson, N. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00005 · Cited by 372
The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings
Rein, D. B., Smith, B. D., Wittenborn, J. S., Lesesne, S. B., Wagner, L. D., Roblin, D. W., Patel, N., Ward, J. W., & Weinbaum, C. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-4-201202210-00378 · Cited by 302
American Gastroenterological Association Medical Position Statement on the Management of Hepatitis C
Dienstag, J. L., & McHutchison, J. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.011 · Cited by 225
Three Broad Modalities in the Natural History of Vertically Acquired Hepatitis C Virus Infection
The European Paediatric Hepatitis C Virus Network (2005) · Clinical Infectious Diseases · doi:10.1086/430601 · Cited by 191

Show all 18 references

Research works printed but not linked: 3

Smith BD, 2011, Hepatology, 54, 554A
1998, MMWR Recomm Rep, 47, 1
Smith BD, 2012, MMWR Recomm Rep, 61, 1

Sorted by citations

Items 301–400 of 475

Hepatitis C Screening Rates and Care Cascade in a Large US Insured Population, 2010–2016: Gaps to Elimination
Tran, J. N., Wong, R. J., Lee, J. S., Bancroft, T., Buikema, A. R., Ting, J., & Terrault, N. A. (2020) · Population Health Management · doi:10.1089/pop.2019.0237 · Cited by 6
Using Lean-Facilitation to Improve Quality of Hepatitis C Testing in Primary Care
Yakovchenko, V., DeSotto, K., Drainoni, M., Lukesh, W., Miller, D. R., Park, A. Y. S., Shao, Q., Thornton, D. J., & Gifford, A. L. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06210-5 · Cited by 9
Hepatitis C Virus Serosorting in People Who Inject Drugs: Sorting Out the Details
Kim, A. Y., & Page, K. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit526 · Cited by 6
“Recent recommendations by the Centers for Disease Control and Prevention [17], endorsed by the US Preventive Services Task Force, call for more widespread HCV testing [18].”
Method
Rising Trends in Emergency Department Visits Associated With Hepatitis C Virus Infection in the United States, 2006-2014
Yin, S., Barker, L. K., Teshale, E. H., & Jiles, R. B. (2019) · Public Health Reports · doi:10.1177/0033354919878437 · Cited by 6
Sustained and cumulative impact of an electronic medical record‐based alert on a hepatitis C birth cohort screening programme
Fimmel, C. J., Khan, M. Q., Belopolsky, Y., Imas, P., Gampa, A., & Sonnenberg, A. (2021) · Journal of Viral Hepatitis · doi:10.1111/jvh.13524 · Cited by 6
Hepatitis C
Chan, J. C. N. (2014) · Disease-a-Month · doi:10.1016/j.disamonth.2014.04.002 · Cited by 6
Implementation of Evidence-Based Recommendations for Preventive Services in the Veterans Health Administration
Ngo‐Metzger, Q., Mabry-Hernandez, I. R., Kim, J., Adsul, P., Higginbotham, L. B., Hoffman-Hōgg, L., Smith, M. W., & Doherty, J. A. (2019) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000217 · Cited by 5
Design of an Enhanced Public Health Surveillance System for Hepatitis C Virus Elimination in King County, Washington
Baer, A., Fagalde, M. S., Drake, C. D., Sohlberg, E. H., Barash, E., Glick, S. N., Millman, A. J., & Duchin, J. S. (2019) · Public Health Reports · doi:10.1177/0033354919889981 · Cited by 5
Diagnostic Challenges of Hepatitis C
Konerman, M. A., & Lok, A. S.-F. (2014) · JAMA · doi:10.1001/jama.2014.306 · Cited by 5
My Treatment Approach to Chronic Hepatitis C Virus
Shiffman, M. L., Long, A., James, A., & Alexander, P. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.04.013 · Cited by 5
The American College of Preventive Medicine Position Statement on Hepatitis C Virus Infection
Allison, R. D., Hale, S. A., Harvey, B. J., Hudson, T.-M. L., Livingston, C. J., Sherin, K. M., Uduhiri, K. A., & Niebuhr, D. W. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.12.001 · Cited by 5
Emerging sexually transmitted diseases: Hepatitis C, lymphogranuloma venereum (LGV), and Mycoplasma genitalium infections
Decker, C. F. (2016) · Disease-a-Month · doi:10.1016/j.disamonth.2016.03.017 · Cited by 5
Audio‐computer‐assisted survey interview and patient navigation to increase chronic viral hepatitis diagnosis and linkage to care in urban health clinics
de la Torre, A. N., Castaneda, I., Ahmad, M., Ekholy, N., Tham, N., Herrera, I., Beaty, P., Malapero, R. J., Ayoub, F., Slim, J., et al. (2017) · Journal of Viral Hepatitis · doi:10.1111/jvh.12744 · Cited by 5
Economically Efficient Hepatitis C Virus Treatment Prioritization Improves Health Outcomes
Cipriano, L. E., Liu, S., Shahzada, K. S., Holodniy, M., & Goldhaber‐Fiebert, J. D. (2018) · Medical Decision Making · doi:10.1177/0272989x18792284 · Cited by 5
“We do not model HCV screening; HCV screening followed by treatment has been shown to be cost-effective in the United States,(68,69) and in 2013, the USPSTF recommended universal screening of individuals born between 1945 and 1965.(5) However, low screening rates persist without direct intervention and, therefore, unde…”
Electronic reminders increase hepatitis C screening, referral, treatment and cure
Jones, H. F., Patel, P., & Sears, D. M. (2018) · Journal of Viral Hepatitis · doi:10.1111/jvh.12988 · Cited by 5
Hepatitis C virus screening at a Veterans Administration Hospital in New York City
Pesola, H. R., Olender, L., Leon, N., Aytaman, A., Hoffman, R. T., & Pesola, G. R. (2020) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000393 · Cited by 5
The State of Hepatitis C Care in the VA.
Belperio, P. S., Fox, R. K., & Backus, L. I. (2015) · Europe PMC (PubMed Central) · Cited by 5
Effect of a Best Practice Alert on Birth-Cohort Screening for Hepatitis C Virus
Khan, M. Q., Belopolsky, Y., Gampa, A., Greenberg, I., Beig, M., Imas, P., Sonnenberg, A., & Fimmel, C. J. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000297 · Cited by 5
Management and treatment of the HCV‐infected kidney transplant patient
Wong, T., & Bloom, R. D. (2018) · Seminars in Dialysis · doi:10.1111/sdi.12766 · Cited by 5
Risk Factors Associated with Linkage to Care among Suburban Hepatitis C-Positive Baby Boomers and Injection Drug Users
Lier, A., Smith, K., Odekon, K., Bronson, S., Taub, E. M., Tharakan, M. A., Kelly, G. J., Patel, P., & Marcos, L. A. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-0249-y · Cited by 5
“This ﬁnding led to the institution of a grade B recommendation by the United States Preventive Services Task Force for a one-time HCV screening of all baby boomers [5], and the enactment of the Hepatitis Testing Law in New York State [6].”
Background
Principles for implementing a population screening strategy for hepatitis C in Spain
Cabezas, J., García, F., Panero, J. L. C., Buti, M., Molero, J., Blasco, A. J., Mercado, P. L. Y. D., & Crespo, J. (2019) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2019.6768/2019 · Cited by 5
Perioperative Management of Hepatitis C in Patients Undergoing Total Joint Arthroplasty
Ross, P. E., Young, J. R., O’Connor, C. M., Anoushiravani, A. A., & DiCaprio, M. R. (2021) · JBJS Reviews · doi:10.2106/jbjs.rvw.20.00223 · Cited by 5
Hepatitis C Screening: The Downstream Dissemination of Evolving Guidelines in a Resident Continuity Clinic
Madhani, K., Aamar, A., & Chia, D. (2017) · Cureus · doi:10.7759/cureus.1441 · Cited by 5
Elimination of Hepatitis C in Portugal: An Urban Legend?
Velosa, J., & Macedo, G. (2020) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000505582 · Cited by 5
Time for the Elimination of Hepatitis C Virus as a Global Health Threat
Ward, J. W., Hinman, A. R., & Alter, H. J. (2020) · doi:10.1002/9781119436812.ch70 · Cited by 5
HCV Testing and Treatment of Adults in the United States: 2014 Through 2021—Data From Two National Commercial Testing Laboratories
Ghany, M. G., Ward, J. W., Baldwin, Z. K., Jiao, S., Shukla, N., Kuznetsova, A., Kaur, J., Kosch, K. J., & Morgan, T. R. M. (2025) · Journal of Viral Hepatitis · doi:10.1111/jvh.70087 · Cited by 4
“In 2020, in response to rising HCV incidence, driven predominantly by increases in injection drug use, the CDC and USPSTF recommended HCV testing for all persons 18–79 years of age [6, 7].”
Implementing Updated Recommendations on Hepatitis C Virus Screening: Translating Federal Guidance Into State Practice
Martin, E. G., Norcott, A. M., Khalid, H., & O'Connell, D. A. (2015) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000000266 · Cited by 4
Dual therapy of grazoprevir and elbasvir for the treatment of hepatitis C infection
Landaverde, C. E., Wells, J. T., Hamner, R., & Goldstein, J. L. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1147346 · Cited by 4
“In addition, meager efforts for general HCV screening have resulted in missed opportunity for education in transmission prevention and risk reduction strategies [3].”
Background
Optimizing Implementation of Hepatitis C Birth-Cohort Screening and Treatment Strategies
Li, Y., Huang, H., Zabinsky, Z. B., & Liu, S. (2017) · MDM Policy & Practice · doi:10.1177/2381468316686795 · Cited by 4
Hepatitis C Screening: Summary of Recommendations From the Clinical Decision Tool
Boldt, M. D., Brill, J. V., Davis, G. L., Gordon, S. C., Kim, A. Y., Kosinski, L. R., Levy, A. G., Nahass, R., & Allen, J. I. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.09.007 · Cited by 4
Screening for hepatitis C in average and high‐risk populations of Qatar using rapid point‐of‐care testing
Sharma, M., Kaabi, S. A., John, A. K., Dweik, N. A., Wani, H. U., Thandassary, R. B., Derbala, M. F. M., Ejji, K. A., Sultan, K., Pašić, F., et al. (2015) · United European Gastroenterology Journal · doi:10.1177/2050640615580725 · Cited by 4
“At present, the United States Preventive Services Task Force recent guidelines do not support screening asymptomatic healthy individuals in the USA but recommends screening only high-risk individuals and single-time screening for adults born between 1945 and 1965—so called ‘baby boomers’.(15) The addition of baby boom…”
Background
Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China
Wu, E., Yang, M., Rao, H., Fu, S., Feng, B., Fei, R., Lin, A., Fontana, R. J., Wei, L., & Lok, A. S.-F. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4619-6 · Cited by 4
Hepatitis C Testing and Liver Fibrosis Predictors in the Birth Cohort of a Primary Care Practice
Bersoux, S., Mi, L., Aqel, B. A., & Dickson, R. C. (2020) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2020.04.003 · Cited by 4
Epidemiology of Gastrointestinal Diseases
Machicado, J. D., Greer, J. B., & Yadav, D. K. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_7-1 · Cited by 4
Occurrence and clinical characteristics of occult hepatitis C virus infection in hemodialysis units at Ismailia, Egypt
Serwah, M., Omar, S. A., Khedr, M. S., & Abdel-hamid, A. E. S. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002075 · Cited by 4
Aligning an emergency department hepatitis C and human immunodeficiency virus testing quality improvement initiative with universal screening recommendations
Cave, B., Laun, K., Sheahan, B., Melendez, A., & Ross, A. S. (2022) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12866 · Cited by 4
Expanded blood borne virus testing in a tuberculosis clinic. A cost and yield analysis
Sewell, J., Capocci, S., Johnson, J., Solamalai, A., Hopkins, S., Cropley, I. M., Webster, D. P., & Lipman, M. C. I. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.10.014 · Cited by 4
Chronic Liver Failure and Hepatic Cirrhosis
Grinspan, L. T., & Verna, E. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-64298-7_2 · Cited by 4
Missed opportunities for prevention and treatment of hepatitis C among persons with HIV/HCV coinfection
Millman, A. J., Luo, Q., Nelson, N. P., Vellozzi, C. J., & Weiser, J. K. (2019) · AIDS Care · doi:10.1080/09540121.2019.1668533 · Cited by 4
“and warrants HCV screening per United States Preventative Services Task Force recommendations (Moyer, 2013).”
Background
HCV-specific lymphocyte responses in individuals with positive anti-HCV but negative HCV-RNA
Sili, U., Kaya, A., Aydın, S., Hondur, N., Mert, A., Tabak, F., Özaras, R., & Öztürk, R. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.04.014 · Cited by 4
Apportioning blame in the North American hepatitis C virus epidemic
Spaulding, A. C., & Miller, L. S. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30002-0 · Cited by 4
The Shift in Emphasis From Risk-Based to Age-Based Hepatitis C Virus (HCV) Testing in the US Tends to Remove Injection Drug Use From Discourse on HCV
Jordan, A. E., & Perlman, D. C. (2016) · Substance Use & Misuse · doi:10.1080/10826084.2016.1225767 · Cited by 4
“The USPSTF published HCV testing recommendations in the Annals of Internal Medicine in 2013 (Moyer, 2013).”
Method
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection
Bichoupan, K., Tandon, N., Martel‐Laferrière, V., Patel, N. M., Sachs, D. M., Ng, M., Schonfeld, E. A., Pappas, A., Crismale, J. F., Stivala, A. C., et al. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i11.551 · Cited by 4
Use of electronic health record clinical decision support tool for HCV birth cohort screening
Fitch, D. N., Dharod, A., Campos, C. L., & Núñez, M. (2017) · Journal of Viral Hepatitis · doi:10.1111/jvh.12729 · Cited by 4
Synthetic Opioid Use and Common Injection-associated Viruses: Expanding the Translational Research Agenda
Blackard, J. T., Brown, J. L., & Lyons, M. S. (2019) · Current HIV Research · doi:10.2174/1570162x17666190618154534 · Cited by 4
Hepatitis C Surveillance in the United States: Past, Present, and Future
Barker, L. K., Doshani, M., Jiles, R. B., & Teshale, E. H. (2025) · Public Health Reports · doi:10.1177/00333549251351880 · Cited by 3
Global Epidemiology of Chronic Hepatitis C Virus Infection
Özaras, R., & Leblebicioğlu, H. (2019) · Springer eBooks · doi:10.1007/978-3-030-03757-4_1 · Cited by 3
Factors Associated With Testing for Hepatitis C Infections Among a Commercially Insured Population of Persons With HIV, United States 2008–2016
King, H., Bull–Otterson, L., Hoover, K. W., Huang, H. Y.-L. A., Zhu, W., & Thompson, W. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa222 · Cited by 3
Hepatitis C Screening and Evaluation: Clinical Decision Tool
Allen, J. I. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.09.008 · Cited by 3
The Natural History of Hepatit is C Viral Infection: Clinical Evaluation and Monitoring
Chin, M. A., Hogan, C. J., & Nguyen, D. L. (2016) · Open Medicine Journal · doi:10.2174/1874220301603010052 · Cited by 3
“Finally, the US Preventative Services Task Force and Center for Disease Control recommends one-time testing of all patients born between 1945 and 1965, regardless of other risk factors, citing the higher prevalence of HCV in patients of this age demographic [14].”
Method
Liver Cancer Among Asian Americans
Jayasekera, C. R., & Nguyen, M. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-41118-7_10 · Cited by 3
Toward ending hepatitis C virus infection: What are the next steps?
Cadieux, G., & Sachdeva, H. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.170274 · Cited by 3
Time to HCV Treatment Disfavors Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center
Sims, O. T., Truong, D. N., Wang, K., Melton, P. A., & Atim, K. (2021) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-01105-5 · Cited by 3
Epidemiology of Gastrointestinal Diseases
Machicado, J. D., Greer, J. B., & Yadav, D. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_7 · Cited by 3
Ionophore-Based Nanosphere Emulsion Incorporating Ion-Exchanger for Picogram Potentiometric Determination of HCV Drug (Daclatasvir) in Pharmaceutical Formulations and Body Fluids
Badawy, S. S., Ahmed, Y. M., Abdel‐Haleem, F. M., & Barhoum, A. (2023) · Chemosensors · doi:10.3390/chemosensors11070385 · Cited by 3
Cure and Control: What Will It Take to Eliminate HCV?
Martinello, M., Hajarizadeh, B., Grebely, J., Matthews, G. V., & Dore, G. J. (2019) · Topics in medicinal chemistry · doi:10.1007/7355_2018_56 · Cited by 3
Awareness, Compliance, and Barriers of 1-Time Hepatitis C Screening in Hospital-Based Providers
Ju, F. B., Dumpe, M. L., Lane, G. B., & Shanks, L. C. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.03.007 · Cited by 3
CARDIOVASCULAR EFFECTS OF ORAL ANTIVIRAL TREATMENT FOR NON-CARDIAC HCV PATIENTS
Allam, S. R. H., Soliman, G. M. M., Sayed, A. A. M. A., Mahdy, A. A., & Aboelhagag, M. M. (2018) · Al-Azhar Medical Journal · doi:10.12816/0052815 · Cited by 3
“Hepatitis C virus(HCV) is a significant public health problem and the leading cause of liver transplantation and hepatocellular carcinoma (Moyer, 2013).”
Background
Impact of hepatitis C status on 20-year mortality of patients with substance use disorders
Accurso, A. J., Rastegar, D. A., Ghazarian, S. R., & Fingerhood, M. (2015) · Addiction Science & Clinical Practice · doi:10.1186/s13722-015-0041-6 · Cited by 3
Uncertainty and the Treatment Experience of Individuals With Chronic Hepatitis C
Reinoso, H. (2016) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2016.01.012 · Cited by 3
Stepwise Development of a Cancer Care Delivery Research Study to Evaluate the Prevalence of Virus Infections in Cancer Patients
Unger, J. M., Hershman, D. L., Arnold, K. B., Loomba, R. S., Chugh, R. K., Hwang, J. P., O’Rourke, M. A., Bhadkamkar, N. A., Wang, L. X., Siegel, A. B., et al. (2016) · Future Oncology · doi:10.2217/fon-2015-0076 · Cited by 3
Patient Understanding of HIV and Hepatitis C Testing in an Emergency Department with an Integrated Program
Anderson, E. S., Pfeil, S. K., Alter, H., & White, D. A. E. (2016) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325957416629551 · Cited by 3
Current Issues Involving Screening for Hepatitis C Virus Infection.
Dieterich, D. T. (2015) · PubMed Central · Cited by 3
Linking hepatitis C virus infection to pre-1994 blood transfusions in female patients
Flores, C. R., Echeagaray, E., Castañeda, G. A. L., Vargas, M. D. L., Montes-González, R., Luna, S., Díaz, L., & Torres, O. (2017) · Medwave · doi:10.5867/medwave.2017.02.6886 · Cited by 3
Management and Treatment of Chronic HBV and HCV Co-Infection and the Impact of Anti-Viral Therapy
Shiffman, M. L., & Gunn, N. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0352-z · Cited by 3
Similarities in Hepatitis C Patient Profiles Over a Decade in an Urban GI Clinic
Rutledge, B. P., Mahajan, V., Naylor, P. H., Benjaram, S., Ehrinpreis, M. N., & Mutchnick, M. G. (2017) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2017.06.739 · Cited by 3
Infectious Disease Issues in Underserved Populations
Grief, S. N., & Miller, J. P. (2018) · Physician Assistant Clinics · doi:10.1016/j.cpha.2018.08.006 · Cited by 3
Management of hepatitis B and C infections in rheumatologic disease
Cheah, J. T. L., Faragon, J. J., & Marks, K. (2018) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.04.001 · Cited by 3
Hepatitis Viruses: Hepatitis C
Perumalswami, P., & Klein, R. S. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7448-8_33 · Cited by 3
Optimal Information Collection Policies in a Markov Decision Process Framework
Cipriano, L. E., Goldhaber‐Fiebert, J. D., Liu, S., & Weber, T. A. (2018) · Medical Decision Making · doi:10.1177/0272989x18793401 · Cited by 3
“The advent of more effective therapy has changed the value of identifying infected individuals, and as a result, the Centers for Disease Control and Prevention (CDC) and the US Preventive Services Task Force (USPSTF) recommended one-time screening of these cohorts in 2013.(36,37) HCV prevalence, and therefore the valu…”
A Big Step Forward in Hepatitis C Screening
Kapila, N., & Muir, A. J. (2020) · Clinical Liver Disease · doi:10.1002/cld.922 · Cited by 3
Another Step Toward Hepatitis C Elimination: An Economic Evaluation of an Irish National Birth Cohort Testing Program
Carty, P. G., Teljeur, C., Gascun, C. F. D., Gillespie, P., Harrington, P., McCormick, P. A., O’Neill, M., Smith, S. M., & Ryan, M. (2022) · Value in Health · doi:10.1016/j.jval.2022.05.010 · Cited by 2
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver disease
Lazarus, J. V., Kopka, C. J., Nicolàs, A., Karim, S. A., Bansal, M. B., Betel, M., Dillon, J. F., Ginès, P., Krag, A. A., Miller, V., et al. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01174-z · Cited by 2
Hepatitis C Virus in the US Military Retiree Population: To Screen, or Not to Screen?
Laufer, C. B., & Carroll, M. B. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2233w · Cited by 2
Hepatitis C Point-of-Care Testing in Vulnerable Populations
Zucker, D. M., & Shanmugam, A. (2016) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000221 · Cited by 2
The Prescribers’ Dilemma: Treatment of Hepatitis C Infection for Medicaid Insured Patients in United States
Khallafi, H., George, N. S., & Qureshi, K. (2015) · Liver Research - Open Journal · doi:10.17140/lroj-1-105 · Cited by 2
Chronic hepatitis C infection: how much are physicians aware of?
Kayar, Y., Kayar, N. B., & Ağın, M. (2019) · Gastroenterology Review · doi:10.5114/pg.2019.85895 · Cited by 2
“The guideline updated by NIH in 2002 was finalized by United States Preventive Services Task Force (USPSTF) in 2013 [15, 25].”
BackgroundMethod
Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review
Walter, L. A., Wilson, L., Farmer, M., Roberson, T., Hand, D. T., & Franco, R. (2023) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2023.07.050 · Cited by 2
Predictors of Limited Quantitative Methodology Use in Clinical Social Work Research: A Survey of Zimbabwean Social Work Students
Muzingili, T. (2025) · Clinical Social Work Journal · doi:10.1007/s10615-025-01001-z · Cited by 4
“Tools like risk assessments are used to predict child abuse, elder abuse, and suicide (Fazel et al., 2012; Moyer, 2013).”
Geriatric Care and the LGBT Older Adult
Clark, M., Zinman, H., & Bomba, E. (2016) · Springer eBooks · doi:10.1007/978-3-319-19752-4_12 · Cited by 2
Electronic health record triggered hepatitis C screening in the ED
Ullo, M., & Sugalski, G. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.03.043 · Cited by 2
The Prevalence and Presumed Etiology of Elevated Aminotransferase Levels in a Pacific Northwest Tribal Community
Scott, J., Kowdley, K. V., Ioannou, G. N., Krantz, E. M., Lallemand, O., Tsosie, U., & Buchwald, D. (2015) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2015.0091 · Cited by 2
Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings
Sims, O. T., & Womack, B. G. (2015) · Social Work in Public Health · doi:10.1080/19371918.2014.1000506 · Cited by 2
“Similarly, the USPSTF recently upgraded testing for HCV from a grade C to a grade B testing recommendation to facilitate HCV testing uptake (Moyer, 2013); and HCV testing is now a standard testing procedure covered by medical insurance without charging a copayment or coinsurance due to the testing…”
Method
Hepatitis C Is Poorly Associated With Drug Use in Cambodian Americans in Lowell, Massachusetts
Yu, C., Gifford, A. L., Christiansen, C. L., & Drainoni, M. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw099 · Cited by 2
Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States
Perumpail, R. B., Wong, R. J., Liu, A., Jayasekera, C. R., Dieterich, D. T., Younossi, Z. M., & Ahmed, A. (2016) · Emerging infectious diseases · doi:10.3201/eid2203.151650 · Cited by 2
Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013
Lynch, J. A., DuVall, S. L., Berse, B., Whatley, A., Pierre, C. S., Oloruntoba, O., & Hunt, C. M. (2016) · Military Medicine · doi:10.7205/milmed-d-15-00523 · Cited by 2
Infectious Disease Complications in People Who Inject Drugs
Santoiemma, P. P., Dinwiddie, S. H., & Angarone, M. (2017) · Psychiatric Annals · doi:10.3928/00485713-20161206-03 · Cited by 2
Retracted: Electronic Clinical Decision Support Intervention to Increase Hepatitis C Screening and Linkage to Care Among Baby Boomers in Urban Safety Net Health Systems
Armstrong, H., Gonzalez-Drigo, M., Norels, G., Taussig, D., Trick, W. E., Diep, L., Zhang, H., Catrambone, J., & Adeyemi, O. M. (2019) · Population Health Management · doi:10.1089/pop.2019.0105 · Cited by 2
Retracted
The Impact of Patient Characteristics on Diagnostic Test Performance
Kozlowski, H. N., Sindhwani, S., & Chan, W. C. W. (2022) · Small Methods · doi:10.1002/smtd.202101233 · Cited by 2
Universal screening for hepatitis C — in for a penny, in for a pound
Garrido, I., & Macedo, G. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04395-z · Cited by 2
Sexually Transmitted Infections in Men
Kodner, C. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-26091-4_10 · Cited by 2
Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2021 Abstracts.
(2021) · Canadian Liver Journal · doi:10.3138/canlivj.4.2.abst · Cited by 2
Non‐targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region
Chastain, C. A., Jenkins, C. A., Rose, M., Moore, D., Parker, D., Cave, B., Crowe, J., Adams, S., Rubio, M. G., Potter, R., et al. (2022) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12819 · Cited by 1
Hepatitis C care cascade in a large academic healthcare system, 2012 to 2018
Nakayama, J. Y., Hertzberg, V., Ho, J. C., Simpson, R. L., & Cartwright, E. J. (2023) · Medicine · doi:10.1097/md.0000000000032859 · Cited by 2
Ankle fusion in patients with chronic hepatitis C
Strotman, P. K., Schmitt, D. R., Schiff, A., & Pinzur, M. S. (2019) · Foot and Ankle Surgery · doi:10.1016/j.fas.2019.01.001 · Cited by 2
Utilizing Electronic Laboratory Reporting Data to Assess the Burden of Hepatitis C in Arizona
Tsang, C. A., Khan, M. A., Brady, S., Erhart, L. M., & Komatsu, K. K. (2019) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000001011 · Cited by 2
Development of an evidence-based model of rapid testing, counseling and referral patients with HIV, HVC and other STDs in Mexican addiction treatment centers
Marín-Navarrete, R., Magis-Rodríguez, C. L., Villalobos-Gallegos, L., Villafuerte-García, A., Pérez-López, A., Ruiz-Herrera, K., Sánchez-Domínguez, R., Ponce-Ramos, M., Morales-Carcaño, A., Bravo-García, E., et al. (2019) · Salud Mental · doi:10.17711/sm.0185-3325.2019.025 · Cited by 2
“…of the US Preventive Services Task Force on the application of rapid testing to all those at increased risk of contracting HIV, HCV and other STIs (Moyer, 2013), and of WHO for the implementation of harm reduction strategies (The Joint United Nations Program on HIV/AIDS [UNAIDS], 2016).”
Background
The Growing Problem of Hepatitis C Virus Infection
Phillips, M., Abboud, J., Abodunde, B., Paul, D. P., & Coustasse, A. (2019) · The Health Care Manager · doi:10.1097/hcm.0000000000000278 · Cited by 2
Epidemiology, Natural History, and Diagnosis of Hepatitis C
Ward, J. W., & Holtzman, D. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00029-x · Cited by 2
Impact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centre
Whitman, T. J., Noyes, C. D., Hale, A. J., Singh, D., DeVoe, S. G., Repp, A. B., Pierce, K. K., Polish, L. B., Kirkpatrick, B. D., Dejace, J., et al. (2021) · BMJ Open Quality · doi:10.1136/bmjoq-2020-001248 · Cited by 2

Authors: Moyer, V. A.
Affiliations: United States Preventive Services Task Force (US)
Corresponding author: Moyer, Virginia A.
ORCID: Moyer, Virginia A.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 2013-09
Volume: 159
Issue: 5
Pages: 349-357
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-159-5-201309030-00672
OpenAlex: W2148959572
Cited by: 475
References: 18
Citations by year: 2026: 2 · 2025: 11 · 2024: 5 · 2023: 8 · 2022: 21 · 2021: 23 · 2020: 40 · 2019: 50 · 2018: 59 · 2017: 57 · 2016: 68 · 2015: 59 · 2014: 52 · 2013: 19
FWCI: 41.16
Type: journal article
Language: en
Open access: closed
Licence: www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: hepatitis C virus, HCV screening, asymptomatic adults, vulnerable populations, hepatitis C treatment, baby boomers, screening guidelines
MeSH terms: Adult, Age Factors, Antiviral Agents, Female, Humans, Mass Screening, Pregnancy, Pregnancy Complications, Infectious, Cost of Illness, Risk Assessment, Hepatitis C, Chronic, Early Diagnosis, Asymptomatic Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks